Abbott Laboratories (NYSE: ABT) and Dexcom (NASDAQ: DXCM) are two leading medical device companies that compete against one ...
DexCom's expanding CGM market, G7 rollout, and global growth momentum position it for gains, despite pricing pressure and ...
Barchart on MSN
DexCom’s quarterly earnings preview: What you need to know
San Diego, California-based DexCom, Inc. (DXCM) is a medical technology company focused on continuous glucose monitoring (CGM ...
Zacks Investment Research on MSN
DexCom (DXCM) upgraded to buy: Here's why
DexCom (DXCM) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Dexcom (DXCM) and Pro Medicus Limited (PMCUF). According to TipRanks.com, Chadha is a 2-star analyst with an average ...
Dexcom develops continuous glucose monitoring (CGM) devices. Diabetic patients use these to track their glucose levels in ...
Looking into the current session, DexCom Inc. (NASDAQ:DXCM) shares are trading at $69.95, after a 0.09% increase. Moreover, over the past month, the stock spiked by 2.13%, but in the past year, fell ...
We recently published an article titled 13 Best Internet of Things (IoT) Stocks to Buy Now. On February 13, Mizuho analyst Anthony Petrone raised the price target on DexCom, Inc. (NASDAQ:DXCM) to $90 ...
In a report released today, Marie Thibault from BTIG maintained a Buy rating on Dexcom, with a price target of $80.00. According to TipRanks, Thibault is an analyst with an average return of -14.5% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results